Home Articles

Articles

Welcome to the ARCHIVE of Pharma Marketing News articles. All articles are FREE! No subscription is required to download these articles from past issues. Articles become available to non-subscribers approximately two months after publication. To obtain articles as soon as they are published, you must subscribe to the email newsletter service. Subscription is free and supported by advertising.

Measuring & Communicating eSuccess – Strategy First, YouTube Later… Maybe

This article is a review of a presentation by Aaron Uydess, Senior eMarketing Manager at Novo Nordisk, made at Eye for Pharma's 3rd eCommunication and Online Marketing Summit held October 23-24, 2008, in Boston, Massachusetts. Uydess presents a best-in-class approach to developing online plans that align with strategy, reduce silos, and measure and merchandise digital strategies across a pharmaceutical marketing organization.

A Novel Approach to Communicating with Physicians

This article describes a patent-pending technology developed by MagicMedia Communications. It offers a novel way for pharmaceutical sales representatives to 'talk' to a doctorÂ…even when face-to-face discussion is not possible!

Pharma Marketing News Vol. 9, #9: NOVEMBER 2010

Welcome to the NOVEMBER 2010 issue of Pharma Marketing News. This is the Executive Summary. This executive summary includes links to ALL the NOVEMBER 2010 articles.

Pharma’s Black Knight Confesses All!

A rview of the book THE WHISTLEBLOWER: Confessions of a Healthcare Hitman.

Do Drug Copay Coupons Drive Up Healthcare Costs?

Coupons for drug co-payments are illegal and drive up long-term health-care costs for all, a consumer group and four trade-union health-insurance plans said in announcing lawsuits against eight pharmaceutical companies. The lawsuits claim that although coupons reduce the consumer's out-of-pocket cost, the health insurer still pays the previously negotiated price to the drug company. With no savings from generics, health plans will need to charge patients more to keep up with rising costs, the lawsuits say.

PinUp: Crocks of Shite: Purdue’s Gambit to Win Hearts & Minds, Celebrities Speaking Science...

Welcome to the October 10, 2017, issue of Pharma Industry News Update (aka PinUp). 'Crock of shite!' is a phrase I borrowed from my Irish friends. You can guess the King's English version. More politely known as 'a pile of poo', the term 'a crock of shit(e)' derives from an ancient Roman custom where people would poo into a pot if they were particularly bored by whichever philosopher happened to be talking rubbish at the time. What Purdue proposes as a way to combat overuse of opioids for pain is not so much boring as it is insulting to our intelligence! And don't get me started on the 'crock of shite' celebrities engage in when shilling for the pharma industry!

A New Estimate of Drug Development Cost

Economic Experts Disagree Wildly on How Much It Costs to Bring a New Drug to Market. How is it that the Tufts estimate is at least 14 TIMES the London School of Economics and Political Science (LSEPS) estimate? 'Make no mistake,' said Tufts. 'Tufts CSDD will vigorously defend the scholarship, integrity, and validity of all its published research studies.'

PinUp: Pharma Sis, FDA & Low Risk mHealth Apps, ADHD industrial complex, SnapChat v....

Welcome to the August 23, 2016, issue of Pharma Industry News Update (aka PinUp). PinUp is published every Tuesday and Friday as part of your Pharma Marketing News subscription service. It features curated pharma industry news and views of topical interest from a variety of sources.

PinUp: Marketers & Adherence, Big Orphan Drug Companies, Phony Ad Award, More…

Welcome to the June 28, 2016, issue of Pharma Industry News Update (aka PinUp). PinUp is published every Tuesday and Friday as part of your Pharma Marketing News subscription service. It features curated pharma industry news and views of topical interest from a variety of sources.

Pfizer Battles to Protect Lipitor Cash Cow

Lipitor Won't Go Gentle Into that Good Generic Night. Pfizer is taking a number of steps to protect it's Lipitor franchise and it hopes that many patients currently taking Lipitor will remain loyal to the brand.

Pharma Marketing News, Blog Posts, Events, Podcasts

- Advertisement -